Therefore, prospective multicenter studies involving a larger cohort should be undertaken to expand our understanding of the ability of leukocyte CH25H expression to distinguish between metastatic and non-metastatic LC patients. The gene discussed is CH25H; the disease is laryngotracheoesophageal cleft.